脑机接口概念持续火热，多家上市公司回应

Core Insights - The brain-computer interface (BCI) sector is gaining significant attention, with multiple listed companies responding to the growing interest in this technology [1][4]. Company Responses - Companies such as Xiangyu Medical and Mailland have reported advancements in their BCI projects, with Xiangyu Medical aiming to enter over 1,000 top-tier hospitals in China and Mailland expecting to obtain its first BCI medical device registration certificate by Q1 2026 [5][6]. - Chengdu Huayi and Yingjixin have highlighted their roles in the BCI hardware segment, focusing on signal processing components essential for BCI performance [6][7]. Strategic Collaborations - Yijia is exploring the integration of BCI technology with embodied intelligence robotics, having signed a strategic cooperation agreement with Mailland to develop applications in smart healthcare [7]. - Yahui Long has announced a strategic partnership with Shenzhen Brain Chain Technology to enhance clinical applications and market expansion of BCI technologies [8]. Investment and Market Potential - Strong Brain Technology has recently secured approximately 2 billion yuan in funding, positioning itself as a major player in the BCI field, second only to Neuralink [8]. - The global BCI market is projected to reach approximately $12.4 billion by 2034, with a CAGR of 17% from 2025 to 2034, indicating substantial growth potential [9]. Industry Outlook - The BCI industry is expected to experience significant development opportunities driven by technological innovations, policy support, and capital investments, with promising prospects in healthcare and consumer markets [10].